GTC
ONC

Ghost Tree Capital’s BeOne Medicines Ltd ONC Stock Holding History

Ghost Tree Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,500
Closed -$4.01M – 82
2023
Q2 		$4.01M Buy
+22,500
New +$5.18M 1.32% 23

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Ghost Tree Capital's ONC Position: Q3 2023 in Review

Ghost Tree Capital sold out of BeOne Medicines Ltd (ONC) in Q3 2023, closing a stake of 22,500 shares — an estimated $4.01M sold.

Ghost Tree Capital first reported a position in ONC in Q2 2023 and held it in 1 quarter. The position peaked at $4.01M in Q2 2023. 200 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

  • Ghost Tree Capital reported no remaining BeOne Medicines Ltd position as of Q3 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 22,500 BeOne Medicines Ltd shares in Q3 2023, an estimated $4.01M.
  • Ghost Tree Capital first reported a position in BeOne Medicines Ltd in Q2 2023 and held it in 1 quarter.
  • Ghost Tree Capital's BeOne Medicines Ltd position peaked at $4.01M in Q2 2023.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Ghost Tree Capital's 13F filing for Q3 2023, filed 14 Nov 2023.